Sources of Funding:
Dose tapering for ciclosporin in cats with nonflea-induced hypersensitivity dermatitis
Article first published online: 27 MAR 2013
© 2013 The Authors. Veterinary Dermatology © 2013 ESVD and ACVD
Volume 24, Issue 3, pages 315–e70, June 2013
How to Cite
Steffan, J., Roberts, E., Cannon, A., Prélaud, P., Forsythe, P., Fontaine, J., King, S. and Seewald, W. (2013), Dose tapering for ciclosporin in cats with nonflea-induced hypersensitivity dermatitis. Veterinary Dermatology, 24: 315–e70. doi: 10.1111/vde.12018
This study was funded by Novartis Animal Health, Basel, Switzerland.
Conflict of Interest:
J.S., E.R., S.K. and W.S. are full-time employees of Novartis Animal Health. A.C., P.P., P.F. and J.F. have received related and unrelated consultancy fees, lecture fees or investigator fees from Novartis Animal Health.
- Issue published online: 14 MAY 2013
- Article first published online: 27 MAR 2013
- Manuscript Accepted: 14 JAN 2013
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!